+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
MALE
ID06130995

Phase 1b Study of Relugolix and Enzalutamide with Radiation or Surgery in Men with High-Risk Locally Advanced Prostate Cancer

Led by University of Oklahoma · Updated on 2026-03-05

46

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the combination of two medications, relugolix and enzalutamide, to see how effective and safe this treatment is for patients with high-risk locally advanced prostate cancer. This phase Ib trial aims to improve outcomes by using these drugs as neoadjuvant and adjuvant androgen deprivation therapy alongside standard treatments, such as radiation therapy or prostatectomy. The study also focuses on understanding changes in biomarkers and overall disease progression. Participants will receive relugolix and enzalutamide orally, with a loading dose of relugolix on the first day followed by daily dosing. The treatment includes six months of neoadjuvant therapy before radiation or surgery, followed by 18 months of maintenance adjuvant therapy. The initial safety phase will enroll up to 12 patients, followed by a dose expansion cohort of up to 29 patients. Treatment duration may change if toxicity occurs or if participants choose to withdraw. During the study, participants will be monitored for side effects and treatment responses, including blood tests and assessments of prostate-specific antigen PSA levels. Researchers will track dose limiting toxicities, pathologic complete response rates, and progression-free survival over several years. The total follow-up period after treatment is expected to be around 24 months to evaluate long-term outcomes and safety.

CONDITIONS

Brief Title

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Research Team

L

lead onco nurse, RN

K

Kelly Stratton, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here